These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29081256)

  • 1. Ternary complex of plasmid DNA with NLS-Mu-Mu protein and cationic niosome for biocompatible and efficient gene delivery: a comparative study with protamine and lipofectamine.
    Nematollahi MH; Torkzadeh-Mahanai M; Pardakhty A; Ebrahimi Meimand HA; Asadikaram G
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1781-1791. PubMed ID: 29081256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protamine/DNA/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: The Role of Protamine.
    Puras G; Martínez-Navarrete G; Mashal M; Zárate J; Agirre M; Ojeda E; Grijalvo S; Eritja R; Diaz-Tahoces A; Avilés-Trigueros M; Fernández E; Pedraz JL
    Mol Pharm; 2015 Oct; 12(10):3658-71. PubMed ID: 26334586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designed multi-domain protein as a carrier of nucleic acids into cells.
    Xavier J; Singh S; Dean DA; Rao NM; Gopal V
    J Control Release; 2009 Jan; 133(2):154-60. PubMed ID: 18940210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: Nematollahi et al., Ternary complex of plasmid DNA with NLS-Mu-Mu protein and cationic niosome for biocompatible and efficient gene delivery: a comparative study with protamine and lipofectamine.
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1992. PubMed ID: 29205060
    [No Abstract]   [Full Text] [Related]  

  • 5. Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery.
    He SN; Li YL; Yan JJ; Zhang W; Du YZ; Yu HY; Hu FQ; Yuan H
    Int J Nanomedicine; 2013; 8():2859-69. PubMed ID: 23990715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery.
    Rajagopalan R; Xavier J; Rangaraj N; Rao NM; Gopal V
    J Gene Med; 2007 Apr; 9(4):275-86. PubMed ID: 17397090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ternary complex of plasmid DNA with protamine and γ-polyglutamic acid for biocompatible gene delivery system.
    Kanda K; Kodama Y; Kurosaki T; Imamura M; Nakagawa H; Muro T; Higuchi N; Nakamura T; Kitahara T; Honda M; Sasaki H
    Biol Pharm Bull; 2013; 36(11):1794-9. PubMed ID: 24189422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protamine sulfate-calcium carbonate-plasmid DNA ternary nanoparticles for efficient gene delivery.
    Wang CQ; Wu JL; Zhuo RX; Cheng SX
    Mol Biosyst; 2014 Mar; 10(3):672-8. PubMed ID: 24442276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.
    Kim NH; Provoda C; Lee KD
    Mol Pharm; 2015 Feb; 12(2):342-50. PubMed ID: 25521817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems.
    Keller M; Harbottle RP; Perouzel E; Colin M; Shah I; Rahim A; Vaysse L; Bergau A; Moritz S; Brahimi-Horn C; Coutelle C; Miller AD
    Chembiochem; 2003 Apr; 4(4):286-98. PubMed ID: 12672108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate.
    Govindarajan S; Sivakumar J; Garimidi P; Rangaraj N; Kumar JM; Rao NM; Gopal V
    Biomaterials; 2012 Mar; 33(8):2570-82. PubMed ID: 22192536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the nuclear delivery and intra-nuclear transcription of plasmid DNA condensed with micro (mu) and NLS-micro by cytoplasmic and nuclear microinjection: a comparative study with poly-L-lysine.
    Akita H; Tanimoto M; Masuda T; Kogure K; Hama S; Ninomiya K; Futaki S; Harashima H
    J Gene Med; 2006 Feb; 8(2):198-206. PubMed ID: 16285003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system.
    Limeres MJ; Suñé-Pou M; Prieto-Sánchez S; Moreno-Castro C; Nusblat AD; Hernández-Munain C; Castro GR; Suñé C; Suñé-Negre JM; Cuestas ML
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110533. PubMed ID: 31593829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core.
    Murray KD; Etheridge CJ; Shah SI; Matthews DA; Russell W; Gurling HM; Miller AD
    Gene Ther; 2001 Mar; 8(6):453-60. PubMed ID: 11313824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery.
    Yuan H; Zhang W; Du YZ; Hu FQ
    Int J Pharm; 2010 Jun; 392(1-2):224-31. PubMed ID: 20230883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic Delivery System of pDNA through Complexes Electrostatically Constructed with Protamine and Chondroitin Sulfate.
    Kodama Y; Nishigaki W; Nakamura T; Fumoto S; Nishida K; Kurosaki T; Nakagawa H; Kitahara T; Muro T; Sasaki H
    Biol Pharm Bull; 2018; 41(3):342-349. PubMed ID: 29491211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient gene therapy with a combination of ultrasound‑targeted microbubble destruction and PEI/DNA/NLS complexes.
    Wang YJ; Zhou Q; Cao S; Hu B; Deng Q; Jiang N; Cui J
    Mol Med Rep; 2017 Nov; 16(5):7685-7691. PubMed ID: 28944824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice.
    Delgado D; Gascón AR; Del Pozo-Rodríguez A; Echevarría E; Ruiz de Garibay AP; Rodríguez JM; Solinís MÁ
    Int J Pharm; 2012 Apr; 425(1-2):35-43. PubMed ID: 22226874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a non-viral gene delivery vector based on the dynein light chain Rp3 and the TAT peptide.
    Favaro MT; de Toledo MA; Alves RF; Santos CA; Beloti LL; Janissen R; de la Torre LG; Souza AP; Azzoni AR
    J Biotechnol; 2014 Mar; 173():10-8. PubMed ID: 24417903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical characterization of the DNA binding and condensing properties of adenoviral core peptide mu.
    Keller M; Tagawa T; Preuss M; Miller AD
    Biochemistry; 2002 Jan; 41(2):652-9. PubMed ID: 11781106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.